Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
about
Nanotechnology-mediated targeting of tumor angiogenesisNanotechnology, nanotoxicology, and neuroscienceQuantum dots to monitor RNAi delivery and improve gene silencingCalcium phosphate nanoparticles-based systems for siRNA deliveryUpdate on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac DiseaseαV integrins in angiogenesis and cancerSmart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapyRNA interference and potential therapeutic applications of short interfering RNAsTherapeutic potential of RNA interference against cancerSystemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory targetPolyethyleneimine mediated DNA transfection in schistosome parasites and regulation of the WNT signaling pathway by a dominant-negative SmMef2RNA Interference and Cancer TherapyTargeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemiaNanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice.Advances in Systemic siRNA DeliveryPreparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects.Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.Engineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an example.Aptamer-targeted cell-specific RNA interferenceEnhancement of antifungal activity by integrin-targeting of branched histidine rich peptides.Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.Polyethyleneimine (PEI) mediated siRNA gene silencing in the Schistosoma mansoni snail host, Biomphalaria glabrata.Integrin alpha(v)beta(3)-Targeted Cancer Therapy.Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.Inhibitory RNA molecules in immunotherapy for cancer.PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.Silica nanoparticles as a delivery system for nucleic acid-based reagents.Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells.Efficient and targeted delivery of siRNA in vivo.Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid TumorsDevice-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.Delivery of siRNA therapeutics: barriers and carriers.Significance and applications of nanoparticles in siRNA delivery for cancer therapy.Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle GrowthIncreased tumor distribution and expression of histidine-rich plasmid polyplexes.
P2860
Q21195857-00FA4408-4BA6-4050-935A-1E7C2A7BAC90Q24650444-178AF218-2B21-43EE-895A-E6063DE047B5Q24811402-FE6C490A-5579-4D39-9303-58D09D094F08Q26744039-8B5E0607-80C1-496B-9690-FAECE6DD2469Q26801907-9BF07D60-E390-4E26-810B-F036A04B04D3Q26851768-6599438B-F91F-4988-825C-05C4F5EFF035Q27025832-0B5CCAE4-20C3-48AF-AD96-E94FC19CD606Q28250480-C7B4A14E-6B27-4F9E-87EF-04DCC1B26AEDQ28253746-F560E24D-3178-4AC7-9A22-C75BF4212C5BQ28266775-9D97351E-F116-4456-9F65-4C9812F22970Q28534853-D84306A1-85FF-4A02-AA2A-F6E29272C024Q29392204-09901D10-DB70-4BB0-8D29-FDBE8A5B8EEFQ30622245-411FBD8B-646C-406A-A57E-80F7A370C4F0Q33326762-45C892F5-2C53-4A33-AC4E-E2E85E877703Q33613316-7EB5F19A-8826-4C72-8CCC-E7432CCDC32CQ33623605-F3FC529B-DE85-46BC-8899-D89827EA5448Q33686536-8C4AFAE7-02B6-4FED-96FF-9D44138CE390Q33713483-83EC820A-8BC2-4BBE-AD42-A338663AB8AEQ33717239-04FBEF73-7D1D-4ED7-AA8B-ED6B17AAB6DCQ33811522-36048D7A-B155-4178-A363-C959E3863E2EQ33885654-AB84E6E4-9003-4F3E-8A66-00CF9DD138BBQ33963996-3130DAD5-CCB3-405A-BB4E-E3187E8DADDFQ33983773-FFB27447-9BCA-4E43-BF7F-F8D349AD68F6Q34001975-EB5D8557-1D38-4697-9F26-12CA932218D5Q34033910-7961D9D7-326D-4468-98FD-9EFD3E4E9CB4Q34069847-ED661CA5-2F57-41CA-B2AC-7909E7322568Q34080775-9438D5A0-FBF9-4070-99B2-CC13A80DE486Q34130093-F8D0A211-DC13-4A50-A47F-B64B5C9B26F3Q34149828-FD9CF16F-1808-4268-965F-97795256AEE4Q34152538-6094A58C-102D-4D64-969E-1FA0DA2FBB6DQ34165321-C0158C43-9DD9-4C89-A869-5F8128F896A5Q34288026-2170FC9B-3D4F-4678-A275-F10E27816AC3Q34293708-CEB02B8A-A80D-4A11-99F4-97CD4EF826B5Q34297263-A6AF2071-1F1B-4F95-90FD-913887B3AA03Q34334362-B2CF65D2-FFB0-4FEA-B6A9-168098722B82Q34354205-4A4FB511-A792-418F-B47B-16B285BB34B9Q34448562-E74BDA09-74F4-4A43-94D5-E5EA31E45B7AQ34488806-B24925B1-EB9D-44C1-A132-207BF70B4676Q34536058-51BC7176-20B6-40DF-9B09-712DEB96AFB2Q34566500-C54F5973-43E6-4F7E-9E49-A5B84ADB047D
P2860
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@ast
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@en
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@nl
type
label
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@ast
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@en
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@nl
prefLabel
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@ast
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@en
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@nl
P2093
P2860
P3181
P356
P1476
Cancer siRNA therapy by tumor ...... ically stabilized nanoparticle
@en
P2093
Aslam Ansari
Gert Storm
Martin C Woodle
Patrick Y Lu
Puthupparampil V Scaria
Qingquan Tang
Raymond M Schiffelers
P2860
P3181
P356
10.1093/NAR/GNH140
P407
P577
2004-11-01T00:00:00Z